Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

March 22-23, 2023 - SACHRP Meeting

March 22, 2023 - March 23, 2023

Materials may be accessed at Regulations.gov, docket # HHS-OASH-2023-0003.

Agenda

Wednesday, March 22, 2023

Time	Agenda Item
11:00 am - 11:15 am	Welcome Doug Diekema, MD SACHRP Chair Julie Kaneshiro Acting Director, OHRP
11:15 am – 11:30 pm	Overview of Government Accounting Office (GAO) Report #GAO-23-104721 Institutional Review Boards: Actions Needed to Improve Federal Oversight and Examine Effectiveness Shannon Legeer Assistant Director Health Care Team, GAO Toni Harrison Senior Analyst Health Care Team, GAO
11:30 pm- 12:30 pm	Speaker Panel: Defining Stakeholders and Evaluating HRPP/IRB Quality and Effectiveness Emily E. Anderson, PhD, MPH Associate Professor, Neiswanger Institute for Bioethics Stritch School of Medicine Loyola University Chicago Holly Fernandez Lynch, JD, MBe Assistant Professor of Medical Ethics and Law Perelman School of Medicine University of Pennsylvania Ann Johnson, PhD, MPH Director, Institutional Review Board University of Utah
12:30 pm – 1:15 pm	SACHRP Discussion with Panelists Moderator- Douglas Diekema, MD SACHRP Chair
1:15 pm – 1:45 pm	BREAK
1:45 pm – 3:00 pm	SACHRP Charge and Recommendation on GAO Report Recommendation #4 David Forster, J.D. Co-chair Subcommittee on Harmonization Susan Kornetsky, MPH Subpart A Subcommittee
3:00 pm - 4:15 pm	Recommendations on Draft FDA Guidance: Ethical Considerations for Clinical Investigations of Medical Products Involving Children Guidance for Industry, Sponsors, and IRBs David Borasky, MPH Subpart A Subcommittee Co-chair
4:15 pm - 4:30 pm	Public Comment
4:30 pm	Adjournment Doug Diekema, MD SACHRP Chair

Thursday, March 23, 2023

Time	Agenda Item
11:00 am - 11:15 am	Welcome Doug Diekema, MD SACHRP Chair Julie Kaneshiro Acting Director, OHRP
11:15 am – 1:00 pm	Recommendations on Draft FDA Guidance: Ethical Considerations for Clinical Investigations of Medical Products Involving Children Guidance for Industry, Sponsors, and IRBs David Borasky, MPH Subpart A Subcommittee Co-chair
1:00 pm – 1:30 pm	BREAK
1:30 pm – 2:30 pm	Recommendations on Draft FDA Guidance: Ethical Considerations for Clinical Investigations of Medical Products Involving Children Guidance for Industry, Sponsors, and IRBs David Borasky, MPH Subpart A Subcommittee Co-chair
2:30 pm – 4:00 pm	Reserved
4:00 pm – 4:15 pm	Public Comment
4:15 pm – 4:30 pm	Adjournment Doug Diekema, MD SACHRP Chair

Webcast URL:

Content created by Office for Human Research Protections (OHRP)
Content last reviewed March 13, 2023